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Aim: Cronobacter sakazakii sequence types 1, 4, 8 and 12 are associated with outbreaks of 
neonatal meningitis and necrotizing enterocolitis infections. However clonality results in 
strains which are indistinguishable using conventional methods. This study investigated the 
use of clustered regularly interspaced short palindromic repeats (CRISPR)–cas loci profiling 
for epidemiological investigations. Materials & methods: Seventy whole genomes of 
C. sakazakii strains from four clonal complexes which were widely distributed temporally, 
geographically and origin of source were profiled. Results & conclusion: All strains encoded 
the same type I-E subtype CRISPR–cas system with a total of 12 different CRISPR spacer arrays. 
This study demonstrated the greater discriminatory power of CRISPR spacer array profiling 
compared with multilocus sequence typing, which will be of use in source attribution during 
Cronobacter outbreak investigations.
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Background
The bacterial pathogen Cronobacter has become the focus of much attention especially due to its 
association with neonatal meningitis [1]. A number of potential virulence traits causing cytopatho-
genicity of host cells have been proposed, most recent being the production of outer membrane 
vesicles [2,3]. The Cronobacter genus is composed of seven species, of which Cronobacter sakazakii 
is the species most frequently isolated from neonatal and infant cases of infection. A curated open 
access multilocus sequence typing (MLST) database has been established for the genus with 
>1400 strains and associated metadata [4–7]. This database has enabled the recognition of certain 
Cronobacter clonal lineages within the genus as pathogenic variants, whereas others are primarily 
commensal organisms of the environment. The major pathovars are C. sakazakii sequence type 
(ST) 4 which is more predominantly associated with neonatal meningitis, C. sakazakii ST12 with 
neonatal necrotizing enterocolitis, C. sakazakii clonal complex (CC) 1 strains are primarily isolated 
from infant formula and clinical sources, whereas C. sakazakii ST8 are isolated from clinical and 
nonformula food sources [6,8,9]. The original 7-loci MLST scheme is congruent with both 53-loci 
ribosomal MLST and 1865-loci core genome MLST as well as whole-genome phylogeny [6]. The 
reason for the predominance of certain pathovars with particular clinical presentations could be 
due to their greater environmental fitness resulting in increased exposure, as well as the possible 
encoding of virulence genes [9].
Although a number of virulence traits have been proposed in C. sakazakii none are unique to 
specific pathovars [10]. However, whole-genome analysis has now been used to generate a capsu-
lar profiling scheme which is based on the K-antigen and colanic acid encoding genes [11]. This 
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scheme revealed that strains of C. sakazakii and 
C. malonaticus, isolated from cases with the most 
severe neonatal clinical presentations (invasive 
meningitis and necrotizing enterocolitis) were 
capsular profile K2:CA2. Whereas the C. saka-
zakii and C. malonaticus strains associated with 
less severe clinical cases tended to be capsular 
profile K1:CA1 [11].
Although pulsed-f ield gel electrophore-
sis (PFGE) is commonly referred to as a ‘gold 
standard’ for genotyping, it has a number of 
limitations with clonal organisms which are 
genetically homogeneous such as Salmonella 
enterica serovar Enteritidis. For example, one 
pulsotype pattern using the restriction enzyme 
XbaI (JEGX01.0004) of S. Enteritidis is the 
most common pulsotype in the CDC database, 
and is given by approximately 45% of all clinical 
isolates [12]. Hence PFGE is unable to distinguish 
all unrelated Salmonella isolates during an epide-
miological investigation. This may also account 
for the observation that the same pulsotype is 
obtained for unrelated clinical C. sakazakii 
strains [6,13].
Other genotyping methods for Cronobacter 
have been published, but none are able to dis-
tinguish strains to the same level as MLST. 
O-serotyping of Cronobacter has been inves-
tigated by several groups. Initially this was 
achieved by applying random fragment length 
polymorphism profiling across the O-antigen 
region and PCR assays targeting the presumed 
conserved serotype-specific genes wzx and 
wzy [14]. These methods were able to distinguish 
a total of seven serotypes in C. sakazakii, thus 
considerably less than the 189 defined sequence 
types for this species [6,15]. The O-antigen analy-
sis has been supported in part by chemical com-
position determination of the frequently isolated 
serotypes C. sakazakii O:1 and O:2 [16,17]. The 
PCR-primer pair approach for O-serotyping has 
been superseded however by allele profiling of 
gnd and galF (encoding 6-phosphogluconate 
dehydrogenase and UTP-glucose-1-phosphate 
uridylyltransferase subunits, respectively). This 
DNA-sequence based method is a more reliable 
and expansive method for O-antigen determi-
nation of Cronobacter [11]. It has expanded the 
defined number of serotypes in the Cronobacter 
genus from 18 to 34. Nevertheless, none of the 
above DNA-banding pattern genotyping meth-
ods for Cronobacter are as discriminatory as 
7-loci MLST which has >450 sequence defined 
STs [6].
High resolution bacterial genotyping meth-
ods can provide opportunities to improve our 
understanding of bacterial population genet-
ics, evolution and epidemiology. In addition, 
popular DNA sequence-based methods such 
as MLST and PFGE have centralized curated 
databases (i.e., PubMLST and PulseNet) with 
open access to facilitate international participa-
tion. Nevertheless, the advances in next gen-
eration DNA sequencing methods have led to 
new genome-based typing schemes with even 
higher resolution than PFGE or MLST. Of par-
ticular current interest are the loci of ‘clustered 
regularly interspaced short palindromic repeats’ 
(CRISPRs) and CRISPR-associated genes (cas) 
protein-coding genes [18].
CRISPRs are reportedly found in approxi-
mately 80% of archeal genomes and approxi-
mately 48% of eubacterial genomes [18]. There 
are a number of different CRISPR–cas systems, 
often named according to their first identi-
fication organism, in other words, Yersinia 
pseudotuberculosis (YPIII), Escherichia coli 
(type I-E), Neisseria meningitidis (Nmeni) and 
Mycobacterium tuberculosis (Mtube) [19].
In general, CRISPR–cas systems have three 
sections: cas gene cluster, an AT-rich leader 
sequence, followed by a CRISPR spacer array 
composed of short (∼24–48 nucleotide) direct 
repeat sequences separated by similarly sized, 
unique spacers which are usually derived from 
mobile genetic elements such as bacteriophages 
and plasmids [19,20]. Cas genes are found in the 
majority of CRISPR-containing genomes and 
when several CRISPRs of the same CRISPR–cas 
system are present in a single genome, then usu-
ally only a single set of cas genes is clustered with 
one of the CRISPRs.
It has been proposed that CRISPR–cas sys-
tems provide adaptive immunity from inva-
sive genetic elements (phages and plasmids), 
regulate lysogeny and biofilm formation [21,22]. 
The AT leader sequence is believed to act as a 
promoter such that the CRISPR spacer array is 
transcribed and processed into small CRISPR 
RNAs (crRNAs). The mature crRNA and some 
Cas proteins target complementary nucleic 
acids, such as an invading phage genome, result-
ing in the degradation of the target DNA [23]. 
This leads to an acquired specific immunity 
against the infection by the bacteriophage [21]. 
Consequently, CRISPR spacer arrays may 
diverge between closely related strains due to 
recent spacer acquisition(s).
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CRISPR–cas loci adapt by acquiring the new 
spacer sequences at the leader proximal end of 
the array. This results in polarity of the array 
as older spacers are at the distal end to the AT 
leader region. In addition, spacers are normally 
lost by deletion in a nonpolar manner to avoid 
an excessive accumulation of spacers in the 
CRISPR array. However there is considerable 
uncertainty over this issue as CRISPRs with 
several hundred spacers have been found, and 
possibly this variation is related to several factors 
such as the organisms’ ecosystem, along with 
phage and plasmid exposure. Horizontal transfer 
of CRISPR and cas genes occurs between strains 
of the same species and even distant species and 
genera [24]. Subsequently not all strains within 
a species will necessarily possess the same sets of 
CRISPR–cas genes.
Many applications have been identified for 
the CRISPR–cas system including gene edit-
ing, evolutionary and phylogenetic studies, as 
well as genotyping for epidemiological investi-
gations [19,25]. The degree of variability in the 
CRISPR–cas system is a useful marker for spe-
cies diversity and evolution. This approach has 
been applied to Yersinia, Salmonella and E. coli 
in the Enterobacteriaceae family for phyloge-
netic, evolutionary and virulence-related analy-
sis [25–27]. Since spacers are added sequentially 
at the leader proximal end and a given spacer is 
rarely acquired twice or duplicated, hierarchical 
relationships can be constructed between strains. 
Consequently, spacer arrays can be used as alter-
native targets for molecular subtyping and may 
offer higher strain resolution than MLST and 
PFGE. Subtyping protocols based on CRISPR–cas 
systems have been proposed for Salmonella and 
these have included combined analysis with multi-
virulence-locus sequence typing and PFGE [28–30]. 
In contrast, CRISPR typing cannot be used for all 
E. coli strains as it is absent from the extra intes-
tinal phylogenetic group B2 but can be used for 
specific identification of enterohemorrhagic and 
Shiga toxin producing E. coli serotypes [27,31,32]. 
This could be linked to the absence of evidence 
for the type I-E CRISPR–cas system having a role 
in adaptive immunity in E. coli, and instead is 
proposed to be involved in different functions such 
as the regulation of endogenous gene expression 
and possible links to virulence [33,34].
Joseph et al. [35] were the first to report a 
CRISPR spacer array in Cronobacter when under-
taking a genus-wide whole-genome comparative 
study. The specific region was located in all 
Cronobacter strains except one, C. sakazakii 680 
(ST8). The genome of the C. dublinensis strain 
582 also showed the presence of two additional 
clusters of CRISPR spacer arrays. However no 
detailed analysis of these arrays was undertaken.
Genotyping using MLST has proven to be 
highly informative and led to the recognition 
of the clonal lineage C. sakazakii ST4 as the 
pathovar associated with fatal neonatal men-
ingitis infections. However, neither MLST nor 
PFGE are able to discriminate between unre-
lated strains within a clonal lineage as occurs in 
clinical sources [13]. Therefore it is necessary to 
investigate more discriminatory DNA sequence-
based methods, such as CRISPR–cas loci profil-
ing. Such analysis may also provide additional 
understanding of the diversity of the species and 
potential virulence mechanisms.
The first objective of this study was to describe 
the CRISPR–cas loci of C. sakazakii and there-
after to investigate its variation within clonal 
groups. In total the genomes for 70 C. sakazakii 
isolates were chosen for detailed CRISPR–cas 
loci analysis. These represented the four major 
C. sakazakii pathovars: ST4, ST12, CC1 and 
ST8 [6]. They were also chosen to enable the 
comparison of variation between related and 
unrelated strains. These genomes are available 
for independent analysis using the Bacterial 
Isolate Genome Sequence database (BIGSdb)-
supported Cronobacter PubMLST open access 
database [6,7].
Materials & methods
●● Bacterial strains
For the in silico analysis of the CRISPR–cas 
loci, a total of 70 whole-genome-sequenced iso-
lates were chosen as representatives of the major 
pathovars for the neonatal pathogen C. sakazakii; 
ST4, ST12, CC1 and ST8. They were geographi-
cally dispersed over 10 countries and temporally 
spread over 64 years (1950–2014) (supplementary 
table 1). Additional metadata can be obtained 
from the open access Cronobacter PubMLST 
database [7]. In order to investigate the potential 
uses of Cronobacter CRISPR spacer array profil-
ing for epidemiological purposes, 20 isolates from 
a 6-month outbreak on an NICU and 26 envi-
ronmental isolates from manufacturing plants in 
three US states collected within a 6-week period 
were included in the selected isolate cohort. For 
genus-wide phylogenetic analysis of cas1 and cas3, 
an additional 130 genomes were accessed from 
the Cronobacter PubMLST database.
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●● DNa sequences
Whole-genome DNA sequences collated at were 
investigated using the Cronobacter PubMLST 
database [7]. In silico analysis of the cas genes was 
carried out using search options, such as BLAST, 
on the Cronobacter PubMLST portal [36].
●● DNa annotation & visualization tools
The PROKKA annotation tool uses the CRISPR 
recognition tool to identify CRISPR–cas loci [37]. 
The cas genes and CRISPR spacer arrays were 
extracted from the corresponding genome 
assemblies in the Cronobacter PubMLST data-
base. These were mainly draft genomes and 
therefore where the full sequence of one or more 
cas genes and/or CRISPR spacer arrays could 
not be determined (due to beginning and end 
of contigs), the entire isolate was removed from 
analysis. Bacterial DNA sequences were investi-
gated using the genome browser and annotation 
tool Artemis [38]. On occasions, spacer sequences 
present within a clonal lineage can differ by one 
single nucleotide polymorphism (SNP) or inser-
tion/deletion (INDEL). It is unknown whether 
these differences have an impact on CRISPR–cas 
immunity system. These spacer sequences were 
therefore considered to be the same but referred 
to as harboring a SNP or INDEL.
●● Phylogenetic analysis
The cas1 and cas3 genes were aligned and phy-
logenetically analyzed in MEGA version 5.2 
using the ClustalW algorithm [39] set to default 
parameters settings. The phylogenetic trees 
were generated using the Maximum Likelihood 
method based on the Tamura–Nei model with 
the additional parameters set to default set-
tings. All phylogenetic trees are drawn to scale 
with branch lengths measured in the number of 
s ubstitutions per site.
Results
●● Diversity of C. sakazakii cRisPR–cas loci
All C. sakazakii isolates harbored the CRISPR–cas 
system subtype defined as Escherichia coli type 
I-E [19]. This comprises a cas gene cluster com-
posed of cas3, cse1, cse2, cas7, cas5, cas6e, cas1 and 
cas2, with CRISPR spacer arrays either adjacent 
or distant to the cas genes cluster (Figure 1).
Notable exceptions to the possession of the type 
I-E CRISPR–cas profile were four of the eight ST8 
isolates which only possessed cas3, which is the sig-
nature gene for type I CRISPR–Cas systems [19]. It 
is plausible that cas3 is the remnant following the 
partial loss of a cas region. Alternatively, cas3 could 
be the result of horizontal gene transfer (HGT). In 
order to investigate this, a phylogenetic analysis of 
the cas3 genes within the C. sakazakii ST8 and the 
whole Cronobacter genus was undertaken. This 
revealed that the cas3 genes were identical within 
the ST8 isolates regardless of the presence of the 
complete cas gene cluster (Figure 2). Since cas1 and 
cas3 are both commonly used for CRISPR–cas 
classification [19], an additional cas1 phylogenetic 
tree was constructed and was found to match that 
of cas3 (data not shown). The latter included all 
ST8 isolates from a total of 208 strains across the 
Cronobacter genus (Figure 2).
The cas3 tree conformed to the expected phylog-
eny across the seven species in the genus (Figure 2). 
It showed the close relatedness of C. sakazakii 
with C. malonaticus, and C. muytjensii with C. 
dublinensis, as well as the subdivision of C. turi-
censis into two clusters. There was high sequence 
variation within the C. dublinensis species, with 
only half of the strains possessing the cas3 genes. 
Despite this diversity within this species, fur-
ther investigation of their CRISPR arrays was 
regarded as outside the scope of this study due to 
their lack of clinical significance.
The cas3 phylogeny within C. sakazakii 
matched the clonal lineages (Figure 2). The only 
difference was the clustering of the C. saka-
zakii CC100 strains with the C. universalis 
strains away from the general C. sakazakii and 
C. malonaticus clades. All C. sakazakii ST8 cas3 
sequences followed the species phylogeny. The 
cas3 of the four major pathovars did not cluster 
together, but were distributed across the species 
(Figure 2).
●● cRisPR spacer array analysis of the 
four C. sakazakii pathovars
Twelve CRISPR spacer arrays were identified 
across C. sakazakii ST4, CC1, ST12 and ST8 
(2, 3, 3 and 4, respectively) and contained a total 
of 32 different direct repeat (DR) sequences and 
154 different spacer sequences (primarily 29bp 
and 32bp long, respectively). Where appropri-
ate, for clarity, the sequence type (ST) is used in 
the CRISPR spacer array designation, in other 
words, ST4-CRISPR2.
●● cRisPR spacer array analysis of the 
C. sakazakii st4 lineage
Twenty-five ST4 isolates were analyzed includ-
ing 14 from an NICU Cronobacter outbreak in 
France [40]. Two groups of CRISPR spacer arrays 
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Figure 1. Cronobacter sakazakii cRisPR–Cas operon architecture with former gene names are given in parenthesis.
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were found in all isolates (Figure 3). CRISPR1 
was identical across all 25 isolates and was com-
posed of eight DRs (four sequence variants) and 
seven unique spacers. The only sequence varia-
tion was in isolate 1886, which encoded a spacer 
containing a SNP or INDEL. CRISPR2 showed 
much greater variation across the 25 isolates with 
different combinations of spacer repeats generat-
ing a total of seven different CRISPR2 profiles. 
This CRISPR array contained 21–24 DRs (three 
sequence variants) and 23 unique spacers. Two 
isolates (6 and 1105) encoded a spacer contain-
ing a SNP or INDEL (different SNPs/INDELs 
corresponding to the same original sequence). 
The CRISPR2 profiles were not geographically 
or temporally associated as identical combina-
tions were shared between isolates of different 
country, year, source and vice versa. For example, 
isolates 1537 and 1542, which were isolated from 
the same country and same year, show differ-
ent CRISPR2 spacer combinations. In contrast, 
the earliest isolate 377 (from 1950, UK) had the 
same profile as isolate 1587 from 2000 (Israel).
With respect to the C. sakazakii ST4 isolates 
from the 1994 NICU outbreak, all had the same 
designated CRISPR2 profile. This profile was 
also found in a clinical strain (558) isolated in 
the Netherlands in 1983, and an isolate (1537) 
from a Germany milk powder factory in 2009.
●● cRisPR spacer array analysis within 
the C. sakazakii cc1 lineage
Twenty-nine CC1 isolates were analyzed 
including 24 from environmental swabs from 
two different US States; two from Oregon and 
22 from Wisconsin. Three CRISPR spacer 
arrays were found in total (Figure 4). CRISPR1 
and CRISPR2 were found in all 29 isolates. 
CRISPR3 was found in seven isolates only, 
and was present in only two out of the 24 US 
e nvironmental isolates.
CRISPR1 displayed an array of 31 DRs (11 
sequence variants) and 30 unique spacers. All 
CRISPR1 arrays were identical across the 29 
isolates apart from isolate 2064 which con-
tained a different 29th DR sequence and isolate 
716 (NICU outbreak strain), which expressed a 
spacer containing a SNP or INDEL. CRISPR2 
displayed an array of 27–28 DRs (six sequence 
variants) and 26 unique and one predefined 
spacers (which was previously defined in ST4-
CRISPR2). All isolates shared the same CRISPR2 
array except for the two US manufacturing plant 
isolates (CFSAN022298 and CFSAN022299) 
from the USA Oregon state which lacked the 
20th DR and spacer. The CRISPR3 of all C. 
sakazakii CC1 strains contained 11–13 DRs (two 
sequence variants) and 12 unique spacers. This 
CRISPR array was absent from the 22 US fac-
tories’ isolates from Wisconsin. The only varia-
tion in CRISPR3 was found in the same two US 
manufacturing plant isolates as above from the 
US Oregon State which lacked the eighth and 
tenth DR and spacer sequences.
●● cRisPR spacer array analysis within 
the C. sakazakii st12 lineage
Eight ST12 isolates were analyzed including 
five from the French NICU outbreak (Figure 5). 
Three CRISPR arrays were identified, which were 
harbored by all eight isolates. The ST12 lineage 
showed highly conserved CRISPR array profiles 
compared with those within the ST4 and CC1. 
CRISPR1 displayed an array of 11–12 DRs (two 
sequence variants) and 11 unique spacers. All 
isolates shared the same CRISPR1 array except 
for two isolates (E764 and 1108) which lacked 
the third DR and spacer. CRISPR2 was identical 
across all eight isolates and displayed an array of 
9 DRs (three sequence variants) and a total of 
eight spacers; seven unique and one predefined 
spacers (which was previously defined in ST4-
CRISPR2). CRISPR3 displayed an array of seven 
to eight DRs (two sequence variants) and a total 
of seven spacers (five unique and two predefined 
spacers), which had previously defined in ST8-
CRISPR3 and ST1-CRISPR3. All isolates within 
the C. sakazakii ST12 lineage shared the same 
cas3
(ygcB)
cse1
(casA)
cse2 cas7
(casC)
cas5
(casD)
cas6e
(casE)
cas1
(ygbT)
cas2 Leader
(ygbF)
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CRISPR3 array apart from two isolates (E764 and 
1108) as for CRISPR1, which had an additional 
DR and spacer in the last position of the array.
●● cRisPR spacer array analysis within the 
C. sakazakii st8 lineage
The genomes of eight ST8 isolates were analyzed 
and four different CRISPR spacer arrays were 
identified (Figure 6). CRISPR1 displayed an array 
of 15–19 DRs (six sequence variants) and 18 
unique spacers, and was only found in four out of 
eight isolates: 5, 513, 1888 and ES35. CRISPR1 
showed variation with three different array com-
binations across these four isolates. Two isolates 
were identical (5 and 1888) and lacked three DRs 
and spacers at the 7th, 11th and 12th positions, 
and one isolate (ES35) lacked the 11th–14th DR 
and spacer sequences. CRISPR2 was present in 
all ST8 isolates and displayed an array of 8–13 
DRs (five sequence variants) and 13 unique 
spacers (including a spacer expressing a SNP or 
INDEL). Variations in CRISPR2 arrays divided 
the isolates into two groups of four isolates; 680, 
NBRC102416T, 2048, 1906 and 513, 5, 1888, 
ES35, respectively. The first group shared the same 
array except for one isolate (1906) which had an 
additional DR and spacer sequence in first posi-
tion on the array. The second group shared the 
2nd–5th and 7th, 8th and 13th. DRs and spacers 
with the first group of isolates and had an addi-
tional five to six DRs and spacers; one additional 
at the sixth position and four additional at posi-
tion 9–12. Isolates 5 and 1888 lacked the DR and 
spacer at the 12th position on the array. Isolate 5 
appears to lack the first few DRs and spacers of 
the array but this could be caused by the assembly 
of this genome whereby the CRISPR array was 
at the start of a contig. Hence the exact profile of 
the array cannot be determined for this isolate. 
CRISPR3 was identical across all eight isolates 
and displayed an array of five DRs (two sequence 
variants) and four unique spacers which includes 
a spacer expressing an SNP or INDEL. The only 
difference is the first spacer of the array showing 
four isolates harboring the sequence as originally 
defined and four isolates harboring the spacer 
with an SNP or INDEL, dividing the isolates into 
the same groups as mentioned in the CRISPR2 
array. CRISPR4 is found in six out of eight isolates 
including isolates 513 and 1888. The CRISPR4 
arrays are identical and displayed three DRs (one 
variant) and two unique spacers.
The presence/absence of CRISPR1 in four out 
of eight isolates and the variation between those Fi
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Figure 3. Cronobacter sakazakii st4 cRisPR spacer array profiles. Grey scale lozenges correspond to direct repeats (DR) and colored 
boxes correspond to interspersed spacers. Lozenges with the same shading correspond to identical DR sequences within the array. 
Differently colored boxes correspond to unique spacers within the array. Gaps represent the absence of a spacer and its corresponding 
DR. Presence and number of asterisks in a spacer (*) indicate the presence and number of SNP(s) or INDEL(s) within the spacer. Spacers 
shared across different CRISPR arrays are indicated by different shapes; (O) ST4-CRISPR2 and CC1-CRISPR2, (◊) ST4-CRISPR and ST12-
CRISPR2, (Δ) CC1-CRISPR3 and ST12-CRSPR3, and (□) ST12-CRISPR3 and ST8-CRISPR3.
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same isolates in CRISPR2 and CRISPR3 cor-
relate with presence/absence of the cas genes as 
given above; isolates 680, NBRC102416T, 2048 
and 1906 lack all of the cas-genes apart from 
cas3.
●● interclonal lineage similarities
Similarities between clonal lineages were iden-
tified, specifically in the DR sequences. These 
were used to enumerate the CRISPR spacer arrays 
within a lineage. CRISPR1 spacer arrays present 
in all four lineages mainly shared one common 
DR sequence, which was found in multiple copies 
throughout the array. Similarly, CRISPR2 arrays 
shared two repeating DR sequences across all four 
lineages. CRISPR3 arrays in lineages CC1, ST12 
and ST8 harbor the same repeating pattern of DR 
sequences. CRISPR4 found in the ST8 lineage is 
unique and harbors a single DR variant.
Discussion
MLST has become a frequently used method 
for genotyping Cronobacter isolates, especially 
as it both speciates and indicates the patho-
var or clonal lineage. However, neither MLST 
nor PFGE are able to discriminate strains 
within highly clonal groups as it occurs in 
Cronobacter. For example, the frequent isola-
tion of unrelated C. sakazakii ST4 strains from 
clinical cases, which were also indistinguish-
able by PFGE [13]. Hence for epidemiological 
purposes, it is necessary to investigate more 
discriminatory methods. Given the increasing 
availability, lowering costs and application of 
NGS tools, there is an increasing trend for 
genome-based genotyping methods, such as 
CRISPR-array profiling. Due to the clinical 
significance of C. sakazakii this species was the 
focus of study.
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Figure 5. Cronobacter sakazakii st12 cRisPR spacer array profiles. Description and footnotes as per 
Figure 3.
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Seventy whole-genome sequenced C. sakazakii 
isolates were selected for detailed CRISPR–cas loci 
profiling. These had been chosen as representa-
tives of the four clinically significant C. sakazakii 
pathovars (ST4, ST12, CC1 and ST8), being 
also widely temporally (64 years) and globally 
(10 countries) distributed in their origin [6].
CRISPR–cas systems are a known adap-
tive immune mechanism in Eubacteria and 
Archaea [19,25]. These are generally regarded as 
providing immunity against foreign genetic 
elements such as phages and plasmids by tar-
geting nucleic acid in a sequence specific man-
ner. However recently it was proposed that the 
CRISPR–cas system in E. coli was not associated 
with adaptive immunity but instead with vari-
ous functions such as DNA repair, regulation of 
gene expression and virulence [31]. Due to their 
conserved nature, CRISPR–cas loci profiling 
could be used for evolutionary analysis [19]. Since 
strains from the same environment can acquire 
whole CRISPR loci, such phylogenetic analysis 
can reveal the o ccurrence of HGT [41].
Previously cas1 has been used for phylogenetic 
analysis of the various CRISPR–cas systems across 
a wide range of bacteria [19]. It is normally used 
due to its reported highly conserved distribution. 
However, in our analysis, four isolates of the eight 
ST8s lacked cas1 and all other cas genes except the 
cas3 gene (Figure 1). This agreed with the specific 
lack of cas genes in C. sakazakii ST8 strain 680 
as previously reported [35]. The possibility that the 
cas3 in C. sakazakii ST8 was acquired through 
HGT was considered by constructing the cas3 
gene phylogeny based on 200 whole genomes from 
all seven Cronobacter species in the genus. It was 
found to support the previously published whole-
genome phylogeny of the Cronobacter genus [6,35]. 
Similarly, the cas1 phylogeny for all strains har-
boring the gene, also matched the whole-genome 
phylogeny (data not shown).
Bacterial strains from the same geographical 
and temporal region should acquire the same 
spacers due to localized exposure to phages 
and plasmids. CRISPR spacer array content 
has previously been strongly associated with 
sequence-based phylogeny and hence could be 
used as a rapid lineage-based detection method 
and as a discriminatory tool for epidemiological 
purposes [19,25,42].
The variability in CRISPR–cas loci was 
investigated further within C. sakazakii, 
and in particular the spacer region of strains 
selected for their clinical relevance and clonal 
lineage. The acquisition of spacers based on 
a CRISPR–cas adaptive immunity function 
would be expected to show geographic- and 
temporal-specif ic variations. However our 
analysis demonstrates that the C. sakazakii 
CRISPR spacer array profiles were neither geo-
graphically nor temporally dispersed. Instead, 
the identified CRISPR arrays and profiles were 
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Figure 6. Cronobacter sakazakii st8 cRisPR spacer array profiles. Description and footnotes as per 
Figure 3. Note: The dotted outlining of the first few DRs and spacers correspond to their absence in  
C. sakazakii isolate 5 due to the start of a contig. 
DR: Direct repeat.
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specific for each clonal lineage (Figures 3 & 4–6). 
Furthermore, CRISPR array profiling was able 
to distinguish strains within a clonal line-
age. For example, of the two CRISPR arrays 
identified in the ST4 lineage, CRISPR1 was 
highly conserved across the 25 isolates, while 
CRISPR2 showed seven variants based on the 
order and presence/absence of DR and spacer 
units (Figure 3). Isolates of the ST8 lineage also 
showed high variability, especially considering 
the small (n = 8) number of isolates analyzed. 
Whereas CC1 and ST12 showed more con-
served CRISPR array patterns (Figures 3 & 4–6).
The four out of eight ST8 isolates lacking the 
majority of the cas genes (except cas3) would 
suggest that the CRISPR arrays harbored on 
the genome are no longer active and hence can-
not process or utilize their transcripts. This was 
previously identified in Pseudomonas aeruginosa 
where certain lineages harbored degenerative 
systems which contained the CRISPR array but 
lacked the cas genes [42]. Since no new spacer 
acquisition was observed in the Cronobacter iso-
lates harboring all of the cas genes, this could 
suggest that active CRISPR–cas systems are not 
necessarily linked to new spacer acquisitions but 
to other functions. This might explain the sud-
den loss of spacers in CRISPR arrays instead of 
a gradual CRISPR array change due to envi-
ronmental exposure, as has also been proposed 
for E. coli [31].
In order to assess whether profiling of the 
CRISPR spacer array region could be used for 
epidemiological purposes, multiple isolates 
from the same geographic location within 
a short time period were included in the 70 
genome cohort. The CRISPR spacer array 
profiles of the 14 C. sakazakii ST4 isolates 
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from a NICU outbreak in France (1994) were 
indistinguishable from each other (Figure 3). 
However the same profile was also found in 
two unrelated strains (558 &1537) from dif-
ferent countries (Netherlands and Germany) 
and decades (1983 and 2009), respectively. 
Therefore specific Cronobacter CRISPR spacer 
array profiles within an outbreak can be used 
as an epidemiological tool, however such spe-
cific profiles cannot necessarily be used glob-
ally. This limitation is common with other 
DNA-prof iling methods, for example the 
use of PFGE analysis for Salmonella serovar 
Enteritidis isolates [12].
Twenty-six environmental isolates from 
three US States had been collected within a 
6-week period. In silico MLST analysis revealed 
that two isolates were belonging to the C. saka-
zakii ST4 lineage and the remaining 24 were 
C. sakazakii CC1. Other studies have also 
reported the common occurrence of C. saka-
zakii, and in particular ST4 and CC1 in up to 
25% of isolates from milk powder-manufactur-
ing plants [6,43,44]. It should be noted that the 
C. sakazakii ST4 pathovar is associated with 
neonatal meningitis through the ingestion of 
contaminated reconstituted infant formula and 
therefore its presence in manufacturing plants 
is undesirable [6,8,9].
Based on their CRISPR array profiles, the two 
C. sakazakii CC1 strains isolated in Oregon were 
distinguishable from the 22 from Wisconsin. The 
Oregon strains lacked DR and spacer sequences 
within two of the three CRISPR arrays present in 
this lineage (Figure 4). Since the C. sakazakii CC1 
isolates within each manufacturing plant were 
indistinguishable from each other, this probably 
indicates colonization of these environments by 
unique strains. This supports the application of 
genetic profiling of Cronobacter strains allowing 
microbial source tracing of isolates from clinical 
cases through food source, to production site.
This is the first study to identify the wide-
spread phylogenetic distribution of CRISPR 
spacer arrays within the four major pathovars of 
C. sakazakii. This analysis has demonstrated that 
the CRISPR array variability can provide greater 
power of differentiation for genotyping within 
clonal lineages. Future studies will expand the in 
silico CRISPR–cas loci profiling across the whole 
Cronobacter genus for the wider study of bacterial 
population diversity, in particular the adult patho-
var C. malonaticus ST7 and the development of 
laboratory-based PCR typing protocols.
conclusion & future perspective
This is the first study to identify the phylogenetic 
distribution of CRISPR–cas loci within the major 
pathovars of C. sakazakii; ST1, 4, 8 and 12. All 
strains encoded the type I-E subtype CRISPR–
cas system with a total of 12 different CRISPR 
spacer arrays, which were not geographically or 
temporally associated. Each C. sakazakii clonal 
lineage could be subdivided into 2–7 CRISPR 
spacer array profiles, according to the direct repeat 
and spacer sequences. All. C. sakazakii neonatal 
meningitis pathovars (ST4) strains from a NICU 
outbreak had indistinguishable CRISPR2 array 
profiles. This study demonstrated the greater dis-
criminatory power of CRISPR spacer array profil-
ing compared with MLST, which will be of use 
in source attribution during Cronobacter outbreak 
investigations. The future use of genome-based 
strain differentiation will become more estab-
lished over the next few years due to more afford-
able sequencing costs, improved availability of 
genomic tools and ease of use of downstream anal-
ysis. CRISPR–cas profiles are increasingly being 
used as global epidemiological tracking tools, and 
collated into curated open access databases. This 
trend is expected to continue as genomic profiling 
becomes the gold-standard for high-level differen-
tiation of clonal organisms, replacing the current, 
often PCR-based, genotyping methods.
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